Aguia Resources identifies thickening mineralisation at Tres Estradas phosphate project

|

Published 02-FEB-2017 13:12 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Aguia Resources (ASX: AGR) has released promising results from drilling undertaken at its Tres Estradas phosphate project located in southern Brazil. The company has now completed 89% of the total 9500 metre drilling program.

AGR has delineated thicker than anticipated intercepts of phosphorus pentoxide with grades up to 3.96% at depths between 120 metres and 160 metres.

Oxidised mineralisation continues to return high-grade material near surface with notable intercepts of 20 metres grading 6.31% phosphorus pentoxide and 31 metres grading 9% phosphorus pentoxide. There were also thinner intercepts grading up to 11.5%.

These results should have a positive impact on the group’s upcoming bankable feasibility study (BFS) as they demonstrate that the mineralised carbonatite is very consistent and continuous both along strike and at depth.

Overall, however, this is an early stage play and as such any investment decision should be made with caution and professional financial advice should be sought.

The latest drill results, as well as those reported on January 17 reveal that certain parts of the deposits are thicker than predicted in the previous resource model.

On this note, Technical Director, Fernando Tallarico said, “Drilling continues to progress very well and we are confident that the additional metres we are adding to the program will further improve the conversion of inferred resources to measured and indicated categories”.

Aguia’s Managing Director, Justin Reid highlighted the fact that these results will be used to determine the size of the pit constrained resource, making them a key factor in terms of calculating the strip ratio and mining costs.

Robust supply demand dynamics

Once these metrics are combined with previous analysis, a vastly improved resource model could improve the value proposition of Tres Estradas, particularly given it is the only local future supply source in southern Brazil, an area where demand for phosphate is growing off an already strong base.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X